Vir Biotechnology, Inc. (VIR) Q3 2024 Earnings
VIR·Reported October 31, 2024·After market close
Vir Biotechnology, Inc. reported Q3 2024 revenue of $2.4M, missed analyst consensus of $9.4M by $7.0M. Diluted EPS came in at $-1.56, missed the $-0.96 consensus by $0.60.
Revenue
$2.4Mmissed by $7.0M
Consensus: $9.4MDiluted EPS
$-1.56missed by $0.60
Consensus: $-0.96
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Vir Biotechnology, Inc.'s Q3 2024 earnings report.
Vir Biotechnology, Inc. (VIR) reported Q3 2024 earnings on October 31, 2024 after market close.
Vir Biotechnology, Inc. reported revenue of $2.4M and diluted EPS of $-1.56 for Q3 2024.
Revenue missed the consensus estimate of $9.4M by $7.0M. EPS missed the consensus estimate of $-0.96 by $0.60.
You can read the 10-Q periodic report (0001628280-24-044995) directly on SEC EDGAR. The filing index links above go to sec.gov.